From simple building blocks to complex specialty ligands, intermediates are the essential foundation upon which modern drug development is built. The purity, stability, and structural integrity of intermediates directly determine the safety, efficacy, and manufacturing cost of the final product. In an era of increasingly stringent global regulations and intense competition in pharmaceutical development, selecting a trusted intermediate supplier is a strategic decision that accelerates timelines, mitigating supply chain risks, and strengthens market competitiveness.
Protheragen offers not just compounds, but fully documented quality assurance, flexible scalability, and technical expertise to support your most challenging synthetic pathways—whether you need peptide intermediates for novel biologics, pharmaceutical intermediates for small-molecule APIs, or specialty intermediates for advanced cross-coupling chemistry.
At Protheragen, we manage the complexities of chemical sourcing so you can focus on innovation. Our portfolio supports every stage of drug development, from early discovery and hit-to-lead optimization to process scale-up and commercial manufacturing. Backed by rigorous quality control, ISO 9001 certification, and a global supply chain, we deliver reliable intermediates that meet the highest industry standards.
We maintain a vast inventory of over 3,000 core intermediates, ensuring that "in-stock" means immediate availability for your most time-sensitive projects.
Time is a critical factor in R&D. Our efficient global logistics ensure fast, reliable delivery, with expedited options available to keep your synthesis on track.
Our supply capabilities are designed to grow with your project. We support everything from milligram-scale laboratory screening to metric-ton industrial production.
Every product is accompanied by a product information file. Upon request, we provide full analytical suites, including COA, MSDS, and structural characterization data (NMR, HPLC, LCMS).
We take pride in our intermediate product lines, which have helped numerous pharmaceutical companies and research institutions overcome synthetic challenges.
Ethan, Founder & CEO
Sarah, Procurement Director
Dr. Emily, R&D Director
Peptide intermediates are key building blocks for synthesizing peptide chains, including protected amino acids, specialty amino acids, linkers, and PEG derivatives. These intermediates support the development of peptide‑based drugs, which demonstrate significant therapeutic potential due to their high activity, excellent targeting properties, and favorable safety profiles.
Protheragen's peptide intermediates are specifically engineered to support advanced synthesis techniques such as ring-closing metathesis (RCM) and click chemistry.
Unusual amino acids introduce structural diversity and conformational constraints into peptides, enhancing stability, bioavailability, and target selectivity.
| Product Name | Cat Number | CAS Number | Application |
| Boc-Aib-OH | INP1676 | 30992-29-1 | Peptide synthesis, helix induction |
| Boc-Chg-OH | INP1682 | 109183-71-3 | Peptide synthesis, hydrophobic residues |
| Boc-Tle-OH | INP1744 | 62965-35-9 | Peptide synthesis, sterically hindered residues |
| Boc-L-Dap(Boc)-OH | INP1734 | 88971-40-8 | Peptide synthesis, orthogonal protection |
| Fmoc-Aib-OH | INP1766 | 94744-50-0 | SPPS, helix induction |
| Fmoc-Chg-OH | INP1779 | 161321-36-4 | SPPS, hydrophobic modification |
| Fmoc-Tle-OH | INP1880 | 132684-60-7 | SPPS, sterically hindered residues |
| H-Aib-OH | INP1898 | 62-57-7 | Peptide synthesis, α‑methyl amino acid |
| H-Chg-OH | INP1908 | 14328-51-9 | Peptide synthesis, cyclohexyl modification |
| H-Hyp-OH | INP1981 | 51-35-4 | Peptide synthesis, collagen mimics |
N‑methylation of amino acids improves peptide stability, enhances membrane permeability, and increases resistance to proteolytic degradation.
| Product Name | Cat Number | CAS Number | Application |
| Boc-MeAla-OH | INP1404 | 16948-16-6 | Peptide synthesis, N‑methylated residues |
| Boc-MePhe-OH | INP1405 | 37553-65-4 | Peptide synthesis, N‑methylated aromatic residues |
| Boc-Sar-OH | INP1411 | 13734-36-6 | Peptide synthesis, sarcosine building block |
| Fmoc-MeAla-OH | INP1415 | 84000-07-7 | SPPS, N‑methylated alanine |
| Fmoc-Sar-OH | INP1432 | 77128-70-2 | SPPS, sarcosine for peptoid synthesis |
Beta‑amino acids introduce conformational constraints and enhance proteolytic stability in peptide therapeutics and foldamers.
| Product Name | Cat Number | CAS Number | Application |
| Boc-beta-HAla-OH | INP0439 | 158851-30-0 | Beta‑peptide synthesis |
| Boc-beta-HPhe-OH | INP0455 | 51871-62-6 | Beta‑peptide synthesis, aromatic residues |
| Boc-beta-HPro-OH | INP0479 | 56502-01-3 | Beta‑peptide synthesis, proline analogs |
| Fmoc-beta-HAla-OH | INP0522 | 193954-26-6 | SPPS, beta‑alanine building block |
| Fmoc-beta-HPhe-OH | INP0541 | 193954-28-8 | SPPS, beta‑homophenylalanine |
| Fmoc-beta-HPro-OH | INP0565 | 193693-60-6 | SPPS, beta‑proline analogs |
Amino acid alcohols serve as valuable building blocks for peptide reduction, protease inhibitors, and chiral auxiliaries.
| Product Name | Cat Number | CAS Number | Application |
| Boc-Alaninol | INP0032 | 79069-13-9 | Peptide synthesis, reduced C‑terminus |
| Boc-Leucinol | INP0054 | 82010-31-9 | Peptide synthesis, chiral building block |
| Boc-Phenylalaninol | INP0058 | 66605-57-0 | Peptide synthesis, protease inhibitors |
| Boc-Prolinol | INP0059 | 69610-40-8 | Chiral auxiliary, peptide synthesis |
| Fmoc-Alaninol | INP0073 | 161529-13-1 | SPPS, reduced peptide bond formation |
| L-Prolinol | INP0106 | 23356-96-9 | Chiral auxiliary, pharmaceutical intermediates |
| L-Valinol | INP0112 | 2026-48-4 | Chiral building block, pharmaceutical synthesis |
Amino acid derivatives with various protecting groups and modifications enable orthogonal protection strategies and selective deprotection.
| Product Name | Cat Number | CAS Number | Application |
| Ac-Ala-OH | INP0121 | 97-69-8 | Peptide synthesis, N‑acetylated residues |
| Ac-Gly-OH | INP0134 | 543-24-8 | Peptide synthesis, N‑acetylated glycine |
| Ac-Phe-OH | INP0140 | 2018-61-3 | Peptide synthesis, N‑acetylated phenylalanine |
| H-Ala-OH | INP0157 | 56-41-7 | Peptide synthesis, L‑alanine |
| H-Gly-OH | INP0311 | 56-40-6 | Peptide synthesis, glycine |
| H-Leu-OH | INP0329 | 61-90-5 | Peptide synthesis, L‑leucine |
| H-Phe-OH | INP0364 | 63-91-2 | Peptide synthesis, L‑phenylalanine |
Fmoc‑protected amino acids are the standard building blocks for solid‑phase peptide synthesis (SPPS), enabling efficient assembly of peptide chains.
| Product Name | Cat Number | CAS Number | Application |
| Fmoc-Ala-OH | INP1160 | 35661-39-3 | SPPS, L‑alanine |
| Fmoc-Arg(Pbf)-OH | INP1175 | 154445-77-9 | SPPS, arginine with Pbf protection |
| Fmoc-Asn(Trt)-OH | INP1180 | 132388-59-1 | SPPS, asparagine with Trt protection |
| Fmoc-Asp(OtBu)-OH | INP1195 | 71989-14-5 | SPPS, aspartic acid with OtBu protection |
| Fmoc-Cys(Trt)-OH | INP1207 | 103213-32-7 | SPPS, cysteine with Trt protection |
| Fmoc-Gly-OH | INP1227 | 29022-11-5 | SPPS, glycine |
| Fmoc-Phe-OH | INP1267 | 35661-40-6 | SPPS, L‑phenylalanine |
| Fmoc-Val-OH | INP1298 | 68858-20-8 | SPPS, L‑valine |
PEG derivatives and linkers enable the conjugation of peptides to various payloads, including fluorescent tags, cytotoxic agents, and targeting moieties for ADC and PROTAC development.
| Product Name | Cat Number | CAS Number | Application |
| Boc-AEEA DCHA | INP1450 | 560088-79-1 | Peptide modification, linker |
| Fmoc-AEEA | INP1459 | 166108-71-0 | SPPS, hydrophilic linker |
| Fmoc-NH-PEG4-Propionic Acid | INP1468 | 557756-85-1 | PEGylation, ADC linker |
| Fmoc-Rink Amide Linker | INP1393 | 145069-56-3 | Solid‑phase synthesis, C‑terminal amide |
| Sieber Linker | INP1399 | 3722-51-8 | Solid‑phase synthesis, acid‑labile linker |
| Fmoc-ANP Linker | INP1391 | 171778-06-6 | Photocleavable linker for SPPS |
| Fmoc-12-Ado-OH | INP1390 | 128917-74-8 | Long-chain spacer for peptide modification |
Pharmaceutical intermediates are essential chemical building blocks for the synthesis of small molecule drugs, including heterocyclic compounds, chiral intermediates, and specialty structures that form the core framework of APIs. Protheragen’s pharmaceutical intermediates support the efficient synthesis of active pharmaceutical ingredients, enabling streamlined drug development and scalable commercial production.
| Product Name | Cat Number | CAS Number | Application |
| N-[(2'-cyano[1,1'biphenyl]-4-yl)methyl]-methyl ester L-valine monohydrochloride | IND0001 | 482577-59-3 | Valsartan intermediate |
| (4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone | IND0002 | 189028-93-1 | Ezetimibe intermediate |
| 4'-Methyl-2-cyanobiphenyl | IND0003 | 114772-53-1 | Sartan drugs intermediate |
| Rosuvastatin calcium R1 | IND0004 | 289042-12-2 | Rosuvastatin calcium intermediate |
| Rosuvastatin calcium Z7 | IND0005 | 147118-36-3 | Rosuvastatin calcium intermediate |
| Rosuvastatin calcium Z8 | IND0006 | 147118-37-4 | Rosuvastatin calcium intermediate |
| (S)-(+)-Glycidyl Phthalimide | IND0007 | 161596-47-0 | Rivaroxaban intermediate |
| Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid | IND0008 | 486460-00-8 | Sitagliptin intermediate |
For a complete list of pharmaceutical intermediates, please visit Intermediates.
Speciality intermediates are advanced ligands and catalysts that enable challenging synthetic transformations, particularly copper‑catalyzed C–N, C–O, and C–S bond formations. Our oxalamide ligands for copper‑catalyzed coupling address long‑standing challenges in cross‑coupling chemistry, enabling efficient synthesis of complex molecules. Protheragen’s speciality intermediates provide researchers and process chemists with reliable tools to overcome synthetic bottlenecks and streamline pharmaceutical development.
| Product Name | Cat Number | CAS Number | Application |
| BTMPO | INS0001 | 957476-07-2 | Cu-catalyzed coupling of hindered secondary amines |
| MNBO | INS0002 | 2072108-68-8 | Cu-catalyzed C–N coupling at ultra-low loadings |
| BFMO | INS0003 | 69010-90-8 | Cu-catalyzed N‑arylation of anilines and amines |
| BTMO | INS0004 | 920366-91-2 | Cu-catalyzed amidation of aryl chlorides |
| MNFO | INS0005 | 2072109-00-1 | Cu-catalyzed amination with aqueous ammonia |
| PMPBO | INS0006 | 1909333-82-9 | Cu-catalyzed diaryl ether synthesis |
| DMPAO | INS0007 | 2903-48-2 | Cu-catalyzed N‑arylation of secondary amines |
| BPMPO | INS0008 | 1809289-04-0 | Cu-catalyzed C–N coupling for API synthesis |
| BHMPO | INS0009 | 1809288-95-6 | Cu-catalyzed hydroxylation of aryl halides |
| PPBO | INS0010 | 1909333-78-3 | Cu-catalyzed diaryl ether formation |
| HMNPC | INS0011 | 2170816-89-2 | Cu-catalyzed sulfone synthesis from aryl chlorides |
Please note: The above products are only a small part of our thousands of intermediates. If you cannot find the product you need, please contact us.
Beyond our extensive product portfolio, we offer comprehensive custom services to support your unique intermediate needs.
Heterocycles, chiral molecules, fluorides, boronates; from milligram to kilogram scale.
SPPS, liquid‑phase synthesis, complex modifications (phosphorylation, glycosylation, fluorescent labeling).
Tailored purification strategies; structural confirmation via NMR, LC-MS, HPLC.
Accelerated/long‑term stability studies; melting point, solubility, logP, particle size.
Protheragen streamlines the procurement and customization of intermediates through a transparent and efficient process.
Submit your product specifications or custom synthesis requirements. Our expert team responds within 24 hours with solutions and quotations.
All intermediates undergo rigorous quality control and testing, with complete documentation available upon request.
Standard delivery within 2-4 weeks to major global markets; expedited shipping available. Our global supply chain ensures stable and reliable delivery.
Secure your supply of premium intermediates today.
Contact us to discuss your needs, request a quotation, or explore our custom synthesis capabilities.
We implement a rigorous quality management system with ISO 9001 certification. Each product undergoes strict quality inspections from raw material procurement to final delivery, ensuring consistent purity and batch-to-batch reproducibility.
Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed
